Clinical Studies: 2003 Start Date

Psoriasis
Sponsor: Centocor, Inc.
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of Single and Multiple Dose Regimens with Subcutaneous XXXXX in Subjects with Moderate to Severe Psoriasis
November 2003 to June 2005

Psoriasis and Psoriatic Arthritis
Sponsor: Amgen, Inc.
A Multicenter, Open-Label to Observe the Effects of XXXXX on Joint and Skin Disease in Subjects with Psoriatic Arthritis
July 2003 to August 2004

Clinical Studies